Myelodysplastic syndromes in childhood: Is the FAB classification relevant? Report of 81 children from a French multicentre study

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 531-540

  Mielot, F ^a   Buisine, J ^a   Duchayne, E ^a   Fenneteau, O ^a   Goasguen, J ^a   Guitard, A M ^a   Maierredelsperger, M ^a   Malet, M ^a   Manel, A M ^a   Bader Meunierj, B ^a   Tchernia, G ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Childhood; FAB classification; Inherited disorders; Myelodysplasia

Indexed keywords

ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN SYNDROME; EPSTEIN BARR VIRUS; HUMAN; MAJOR CLINICAL STUDY; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; PEDIATRICS; PRIORITY JOURNAL; REFRACTORY ANEMIA; VIRUS INFECTION;

EID: 7144227265     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058361     Document Type: Article

References (23)

1. Raza, A., Mundle, S., Shelly, V., Alvi, S., Chopra, H., Span, L. et al. ( 1996). Novel insighls into the biology of myelodysplastic syndromes: excessive apopotsis and ihe role of cytokines. International Journal ofHematohgy, 63, 265-78.
2. Bennett, J. M., Calovsky, D., Daniel, M. T., Flandrin, G., Gallon, D. A. G., Gralnick, H. R. and Sultan, C. (1982). Proposals for the classification of the myelodysplastic syndromes. British Journal ofHaeinatology, 51, 189-99.
3. Hasle, H. (1994). Myelodysplastic syndromes in childhood.Classification, Epidemiology and Treatment. Leukemia and Lymphoma, 13, 11-26.
4. Brandwein, J. M., Horsman, D. E., Eaves, A. C, Eaves, C. J., Massing, B. G., Wadsworth, L. D., Rogers, P. C. J., Kalousek, D. K. (1990). Childhood myelodysplasia-Suggested classification of myelodysplastic syndromes based on laboratory and clinical findings. American Journal Pediatric Hematology and Oncology, 12, 63-70.
5. Locatelli, F., Zecca, M., Pession, A., Maserati, E., De Stefano, P. and Seven, F. (1995). Myelodysplastic syndromes: The pediatrie point of view. Haematologica, 80, 268-79.
6. Bader-Meunier, B., Mielot, F., Tchernia, G., Buisine, J., Delsol, G., Duchayne, E., et al. (1996). Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. British. Journal of Haematology, 92, 344-50.
7. Creutzig, U., Cantu-Rajnoldi, A., Ritter, J., Romitti, L., Odenwald, E., Contes, V. et al. (1987). Myelodysplastic syndromes in childhood-Report of 21 patients from Italy and West Germany. American Journal of Pediatric Hematology and Oncology, 9, 324-30.
8. Evans, J. P., Czepulkowski, B., Gibbons, B., Swansbury, G. J. and Chessels, J. (1988). Childhood monosomy 7 revisited. British Journal of Haematology, 69,41-8.
9. Tuncer, M. A., Pagliuca, A., Hicsonmez, G., Yetgin, S., Ozsoylu, S. and Mufti, G. J. (1992). Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. British Journal of Haematology, 82, 347-53.
10. Third MIC Cooperative study group (1988). Recommendations for a morphologic, immunologie and cytogenetic (MIC) working classification of the primary and therapyrelated myelodysplastic disorders. Cancer Genetics and Cytogenetics, 32, 1-10.
11. Seymour, J. F. and Estey, E. H. (1993). The prognostic significance of Auer rods in myelodysplasia, British Journal of Haematology. 85 67-76.
12. Verhoef, G. E. G., Pittaluga, S., De Wolf-Peelers, C. and Boogaerts, M. A. (1995). FAB classification of myelodysplastic syndromes: merits and controversies. Annals of Hematology, 71 3-11.
13. Zipursky, A., Peelers, M. and Poon, A. (1987). Megakaryoblastic leukemia and Down's syndrome. Pédiatrie Hematology/Oncology, 4,211-5.
14. Stollmann, B., Fonatsch, C. and Havers, W. (1985). Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. British Journal of Haematology, 60, 183-96.
15. Lutz, P., Follea, G., Albert, A., Falkenrodt, A., Jung, J. J., Masson, E. and Levy, J. M. (1988). Place de la greffe allogénique de moelle osseuse dans la leucéemie myélomonocytaire chronique juvénile. Presse Médicale, 17, 2113-6.
16. Herrod, H. G., Dow, L. W. and Sullivan, J. L. (1983). Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: Immunologie and hématologie studies. Blood, 61, 1098-104.
17. Sommelet, D., Thollot, F., Buisine, J. and Bordigoni, P. (1992). Les myélodysplasies de l'enfant. Annales médicales de Nancy et de l'Est, 31, 55-63.
18. Pagliuca, A., Layton, D. M., Manoharam, A., Gordon, S., Green, P. J. and Mufti, G. J. (1989). Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. British Journal of Haematology, 71, 499-504.
19. Marsh, J. C. W. and Geary, C. G. (1991). Is aplastic anaemia a preleukemic disorder? British Journal of Haematology, 77, 447-52.
20. Tsuge, L, Kqjima, S., Matsuoka, H., Abe, T., Kamachi, Y., Toni, S. and Matsuyama, T. (1993). Clonal haematopoiesis in children with acquired aplastic anaemia. British Journal Haematology 84, 137-43.
21. Gattermann, N., Aul, C. and Schneider, W. ( 1993). Is acquired Idiopathic Anemia (AISA) A Disorder of Mitochondria! DNA? Leukemia, 7, 12 (Dec), 2069-76.
22. Bader-Meunier, B., Rötig, A., Miélot, F., Lavergne, J. M., Croisille, L., Rustin, P. et al. (1994). Refractory anaemia and mitochondria! cytopathy in childhood. British Journal of Haematohgy, 87, 381-5.
23. Tchernia, G., Bader Meunier, B., Lavergne, J. M., Miélot, F. and Dommergues, J. P. (1996). Myelodysplasia in childhood may be a polyclonal disease. Hematology and Cell Tlierapy, 38,325-30.